Stage IIIA Colorectal Cancer AJCC v8 Withdrawn Phase 2 Trials for Rintatolimod (DB16425)

IndicationStatusPhase
DBCOND0109857 (Stage IIIA Colorectal Cancer AJCC v8)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04119830Rintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal CancerTreatment